Troubled Maryland Plant Told to Toss Part of the J&J Vaccine Ingredient it Manufactured

Federal health regulators have instructed the Emergent BioSolutions plant in Baltimore to scrap some batches — millions of doses worth — of the Johnson & Johnson COVID-19 vaccine substance it manufactured. Photo from the Executive Office of the Governor.
Laura Olson
Laura covers the nation's capital as a senior reporter for States Newsroom. Her areas of coverage include politics and policy, lobbying, elections, and campaign finance. Before joining States Newsroom, Laura was the Washington correspondent for the Allentown Morning Call, where she covered Pennsylvania's congressional delegation, public policies affecting the state, and federal elections. She also wrote about Pennsylvania state politics for the Pittsburgh Post-Gazette and Capitolwire.com, and covered the California state capital for The Associated Press and the Orange County Register. A Nebraska native, Laura has a bachelor's degree from Northwestern University, where she studied journalism and political science.